With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead toward regulatory filings for the novel HIV regimen. In Gilead's ...
FOSTER CITY, Calif., December 15, 2025--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive topline results from the Phase 3 ARTISTRY-2 trial. The double-blind trial ...
A man charged with involuntary manslaughter in the death of his friend said he regrets punching the victim, accepts responsibility and wants it known he fully cooperated with police. Trent Gray, 55, ...
ARTISTRY-1 trial showed BIC/LEN is effective in maintaining viral suppression in HIV patients previously on complex ART regimens. BIC/LEN offers a single-tablet alternative for patients with drug-drug ...
This is the shocking moment a tourist was knocked out by another reveller on a party strip in Phuket. Footage shows the pair squaring up to each other in the notorious Soi Bangla area of the holiday ...
Gilead Sciences has developed an industry-leading HIV portfolio in recent years with its megablockbuster daily treatment Biktarvy and its new long-acting pre-exposure prophylaxis (PrEP) medicine ...
Results from ARTISTRY trials will be submitted to regulatory agencies for review. Topline results were announced from a phase 3 trial evaluating bictegravir 75mg/lenacapavir 50mg (BIC/LEN), an ...
A father-to-be was killed with a single punch in a brawl outside an Arizona bar mere weeks before his baby was due, according to authorities and reports. Thomas John “TJ” Pizzitola was found lying ...
Sucker Punch Productions Co-Founder Brain Fleming has indicated the Ghost of Yotei developer will remain committed to working on a single project at any one time. Speaking during an interview with VGC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback